MDGS — Medigus Cashflow Statement
0.000.00%
Last trade - 00:00
- $4.25m
- $13.92m
- $91.86m
- 15
- 85
- 11
- 30
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -14.2 | -6.84 | 4.15 | -10.1 |
Depreciation | ||||
Non-Cash Items | 10.1 | 0.687 | -9.64 | 2.15 |
Unusual Items | ||||
Equity in Net Earnings/Losses | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | 1.28 | -0.156 | -0.083 | -0.946 |
Change in Accounts Receivable | ||||
Change in Inventories | ||||
Change in Other Assets | ||||
Change in Accounts Payable | ||||
Change in Accrued Expenses | ||||
Change in Payable / Accrued Expenses | ||||
Change in Taxes Payable | ||||
Change in Other Liabilities | ||||
Other Operating Cash Flow | ||||
Cash from Operating Activities | -2.69 | -6.14 | -5.25 | -5.66 |
Capital Expenditures | -0.062 | -0.324 | -5.14 | -0.074 |
Purchase of Fixed Assets | ||||
Purchase / Acquisition of Intangibles | ||||
Other Investing Cash Flow Items | -4.06 | -1.28 | -7.3 | -4.4 |
Acquisition of Business | ||||
Sale of Business | ||||
Sale/Maturity of Investment | ||||
Change in Net Investments | ||||
Purchase of Investments | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | -4.12 | -1.6 | -12.4 | -4.48 |
Financing Cash Flow Items | 3.2 | — | 1.92 | 0 |
Other Financing Cash Flow | ||||
Total Cash Dividends Paid | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 3.16 | 22.9 | 19.1 | 5.41 |
Foreign Exchange Effects | ||||
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | -3.59 | 15.3 | 1.66 | -3.96 |